drugset / Trial / NCT00426608

To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.

NCT00426608 ↗

Phase 1 Completed 20 enrolled GlaxoSmithKline
RandomizedCrossoverDiagnostic

Summary

A study to investigate the effects GSK561679 on part of the body's system that controls the balance of many of the hormones (including cortisol).

Timeline

Start
2006-10-06
Primary completion
2007-01-08
Completion
2007-01-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Alprazolam Small molecule 0.25 mg —
Subject VERUCERFONT Small molecule 10 mg —
Subject VERUCERFONT Small molecule 50 mg —
Subject VERUCERFONT Small molecule 200 mg —
Subject VERUCERFONT Small molecule 400 mg —
Background Metyrapone Small molecule 0.04 g/kg —

Indications

No indication recorded.